Patients Derived Organoids in Ovarian Cancer
Conditions: Ovarian Cancer Interventions: Procedure: Blood sample Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Epithelial Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer Interventions: Drug: KAND567; Drug: Carboplatin Sponsors: Kancera AB; Nordic Society of Gynaecological Oncology - Clinical Trials Unit Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials
The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer
Conditions: Epithelial Ovarian Cancer Interventions: Drug: Niraparib Sponsors: Asan Medical Center; Samsung Medical Center; Seoul National University Hospital; Severance Hospital; Gangnam Severance Hospital; Keimyung University Dongsan Medical Center; Kyungpook National University Chilgok Hospital; Seoul St. Mary ' s Hospital; National Cancer Center, Korea; Pusan National University Yangsan Hospital; Inje University; Pusan National University Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials
Low vs. Air Oxygen Concentration CAPA-IVM Culture of Cumulus-oocyte Complexes
Conditions: IVM; PCOS (Polycystic Ovary Syndrome) Interventions: Other: The way of Cumulus-oocyte complexes (COC) CAPA-IVM culture condition Sponsors: M ỹ Đức Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials
A Study of Sovilnesib in Subjects With Ovarian Cancer
Conditions: High Grade Serous Adenocarcinoma of Ovary; Fallopian Tube Cancer; Primary Peritoneal Carcinoma; Chromosomal Instability Interventions: Drug: Sovilnesib Sponsors: Volastra Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials
A Phase Ib Study of Sovilnesib in Subjects With Ovarian Cancer
Conditions: High Grade Serous Adenocarcinoma of Ovary; Fallopian Tube Cancer; Primary Peritoneal Carcinoma; Chromosomal Instability Interventions: Drug: Sovilnesib Sponsors: Volastra Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials
Evaluation of the Effects of Diosmin/Hespiridin Combination on the Clinical Outcomes in Patients With Polycystic Ovary Syndrome
Conditions: Poly Cystic Ovary Syndrome Interventions: Drug: Daflon; Drug: Combined oral contraceptive; Drug: Metformin Sponsors: Ain Shams University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials
Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy
Conditions: Ovarian Cancer Interventions: Drug: Pembrolizumab; Drug: Bevacizumab; Drug: Cyclophosphamide Sponsors: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials
Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging
Conditions: High Grade Serous Ovarian Cancer Interventions: Biological: Blood sample and tissue sample Sponsors: Institut du Cancer de Montpellier - Val d ' Aurelle Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials
Voice Analysis in Women With Polycystic Ovary Syndrome
Conditions: Voice Change Interventions: Diagnostic Test: Acoustic Analysis by MDVP Sponsors: Minia University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials
Fluzoparib Combined With Apatinib in Relapsed Ovarian Carcinoma Maintenance Treatment
Conditions: Relapsed Ovarian Cancer Interventions: Drug: Fluzoparib; Drug: Apatinib Sponsors: Jin Li Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
The Effect of " KB-120 " Small Molecular Nutrient in Women With Decreased Ovarian Reserve
Conditions: Diminished Ovarian Reserve Interventions: Dietary Supplement: " KB-120 " small molecular nutrient and vitamin E; Dietary Supplement: Vitamin E Sponsors: Women ' s Hospital School Of Medicine Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
Theratechnologies Announces Dosing of First Patient in Updated Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer
Milestone for Company’s lead peptide-drug conjugate candidate follows FDA acceptance of protocol amendment for Phase 1 study on June 2, 2023
MONTREAL, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc.... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 12, 2023 Category: Pharmaceuticals Source Type: clinical trials
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Conditions: Low Grade Serous Ovarian Cancer Interventions: Drug: avutometinib + defactinib; Drug: Investigator Choice of Treatment (ICT) Sponsors: Verastem, Inc.; GOG Foundation; European Network of Gynaecological Oncological Trial Groups (ENGOT) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2023 Category: Research Source Type: clinical trials
A Proof of Concept Study to Evaluate Exosomes From Human Mesenchymal Stem Cells in Women With Premature Ovarian Insufficiency (POI)
Conditions: Premature Ovarian Insufficiency; Diminished Ovarian Reserve Interventions: Drug: EV-Pure ™ Sponsors: Vitti Labs, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2023 Category: Research Source Type: clinical trials
